These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 31188771

  • 1. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report.
    Marinova VV, Slavchev SA, Patrikov KD, Tsenova PM, Georgiev GP.
    Folia Med (Plovdiv); 2018 Dec 01; 60(4):637-640. PubMed ID: 31188771
    [Abstract] [Full Text] [Related]

  • 2. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R.
    World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843
    [Abstract] [Full Text] [Related]

  • 3. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 4. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May 05; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant denosumab for extensive giant cell tumor in os ischium: a case report.
    van der Heijden L, van de Sande MA, Hogendoorn PC, Gelderblom H, Dijkstra PD.
    Acta Orthop; 2015 Jun 05; 86(3):393-5. PubMed ID: 25684041
    [No Abstract] [Full Text] [Related]

  • 6. Preoperative Denosumab plus Surgery in the Management of Giant Cell Tumor of Bone: A Comprehensive Narrative Literature Review.
    Abu-Zaid A, Alaqaili SI, Ahmad SO, Bin Hazzaa I, Alharbi H.
    Gulf J Oncolog; 2019 May 05; 1(30):67-75. PubMed ID: 31242985
    [Abstract] [Full Text] [Related]

  • 7. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab.
    Mak IW, Evaniew N, Popovic S, Tozer R, Ghert M.
    J Bone Joint Surg Am; 2014 Aug 06; 96(15):e127. PubMed ID: 25100780
    [Abstract] [Full Text] [Related]

  • 8. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun 06; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 9. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.
    Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU.
    Ann Diagn Pathol; 2020 Apr 06; 45():151479. PubMed ID: 32088577
    [Abstract] [Full Text] [Related]

  • 10. Denosumab for an inoperable giant cell tumour of the ischial bone.
    Paul AG, See LP, Ohn MH, Ohn KM.
    BMJ Case Rep; 2023 Dec 18; 16(12):. PubMed ID: 38110341
    [Abstract] [Full Text] [Related]

  • 11. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
    Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C.
    Clin Orthop Relat Res; 2020 May 18; 478(5):1076-1085. PubMed ID: 31794487
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
    Rosario M, Takeuchi A, Yamamoto N, Hayashi K, Miwa S, Higuchi T, Abe K, Taniguchi Y, Aiba H, Tanzawa Y, Murakami H, Tsuchiya H.
    Anticancer Res; 2017 Feb 18; 37(2):749-754. PubMed ID: 28179326
    [Abstract] [Full Text] [Related]

  • 13. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
    Kinoshita H, Orita S, Yonemoto T, Ishii T, Iwata S, Kamoda H, Tsukanishi T, Inage K, Abe K, Inoue M, Norimoto M, Umimura T, Fujimoto K, Shiga Y, Kanamoto H, Furuya T, Takahashi K, Ohtori S.
    J Med Case Rep; 2019 Apr 26; 13(1):116. PubMed ID: 31023361
    [Abstract] [Full Text] [Related]

  • 14. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D, A Taguibao R, A Strle N, E Burns J.
    Skeletal Radiol; 2017 Apr 26; 46(4):571-578. PubMed ID: 28188337
    [Abstract] [Full Text] [Related]

  • 15. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
    Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW.
    JBJS Case Connect; 2016 Apr 26; 6(3):e74. PubMed ID: 29252651
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 26; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A, Tsuchiya H, Ishii T, Nishida Y, Abe S, Matsumine A, Kawai A, Yoshimura K, Ueda T.
    BMC Musculoskelet Disord; 2016 Jul 22; 17():306. PubMed ID: 27448567
    [Abstract] [Full Text] [Related]

  • 18. An eggshell-like mineralized recurrent lesion in the popliteal region after treatment of giant cell tumor of the bone with denosumab.
    Akaike K, Suehara Y, Takagi T, Kaneko K, Saito T.
    Skeletal Radiol; 2014 Dec 22; 43(12):1767-72. PubMed ID: 25052539
    [Abstract] [Full Text] [Related]

  • 19. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H.
    Curr Opin Oncol; 2020 Jul 22; 32(4):332-338. PubMed ID: 32541321
    [Abstract] [Full Text] [Related]

  • 20. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR, Patel DB, Schein AJ, White EA, Menendez LR.
    Skeletal Radiol; 2015 Jul 22; 44(7):1027-31. PubMed ID: 25712768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.